Related Experiment Video
Updated: Dec 23, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Transverse myelitis associated with Crohn's disease: an exceptional case, idiopathic or secondary?
Guillermo Castillo López1, Mercedes Lumbreras Cabrera2
1Digestivo, Hospital Universitario de Móstoles, España.
Abstract:
Transverse myelitis (TM) is a serious inflammatory disorder of the spinal cord. The annual incidence is 1 to 5 cases per million people. It produces sensory, motor and autonomic symptoms. Once metabolic and vascular causes and demyelinating diseases have been ruled out, they can be classified as paraneoplastic, parainfectious (up to half debut after infection), toxic-pharmacological (TNFα receptor inhibitors can induce TM) or associated with systemic diseases (Lupus). After a complete study, up to 30 % are considered idiopathic.
Insights
Transverse myelitis (TM) is a serious spinal cord inflammation affecting 1-5 per million annually. Causes include infections, autoimmune diseases, and medications, with 30% remaining idiopathic.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Transverse myelitis (TM) is a rare, severe inflammatory condition impacting the spinal cord.
- It manifests with significant sensory, motor, and autonomic nervous system dysfunction.
- The annual incidence rate ranges from 1 to 5 cases per million individuals.
Purpose of the Study:
- To outline the classification and potential etiologies of transverse myelitis.
- To provide an overview of the clinical presentation and diagnostic considerations for TM.
- To highlight the diverse range of conditions associated with this spinal cord disorder.
Main Methods:
- Literature review of transverse myelitis etiological factors.
- Analysis of classification criteria for TM subtypes.
- Summary of clinical manifestations and diagnostic workup.
Main Results:
- Exclusion of metabolic, vascular, and demyelinating diseases is crucial for TM diagnosis.
- Identified causes include paraneoplastic, parainfectious, toxic-pharmacological (e.g., TNFα inhibitors), and systemic diseases (e.g., Lupus).
- Idiopathic cases account for up to 30% of all transverse myelitis diagnoses after comprehensive evaluation.
Conclusions:
- Transverse myelitis presents a complex diagnostic challenge with varied underlying causes.
- Prompt identification and classification are essential for appropriate patient management.
- Further research into idiopathic TM is warranted to elucidate underlying mechanisms.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

